4.6 Review

HIV, Combination Antiretroviral Therapy, and Vascular Diseases in Men and Women

期刊

JACC-BASIC TO TRANSLATIONAL SCIENCE
卷 7, 期 4, 页码 410-421

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacbts.2021.10.017

关键词

combination antiretroviral therapy; endothelial dysfunction; HIV; sex differences

资金

  1. NIH [1R01HL147639-01A1]
  2. AHA [19EIA34760167, 21PRE830396]

向作者/读者索取更多资源

The introduction of combination antiretroviral therapy has increased the life expectancy of people living with HIV, but has also made them more susceptible to cardiovascular disease. Both viral infection and antiretroviral therapy contribute to endothelial dysfunction, which is a major factor in the development of atherosclerosis-related cardiovascular disease, especially in females.
Thanks to the advent of combination antiretroviral therapy (cART), people living with human immunodeficiency virus (HIV) (PLWH) experienced a marked increase in life expectancy but are now at higher risk for cardiovascular disease (CVD), the current leading cause of death in PLWH on cART. Although HIV preponderantly affects men over women, manifestations of HIV-related CVD differ by sex with women experiencing greater risks than men. Despite extensive investigation, the etiopathology of CVD, notably the respective contribution of viral infection and cART, remain illdefined. However, both viral infection and cART have been reported to contribute to endothelial dysfunction, the precursor and major cause of atherosclerosis-associated CVD, through mechanisms involving endothelial cell activation, inflammation, and oxidative stress, all leading to reduced nitric oxide bioavailability. Therefore, preserving endothelial function in PLWH on cART should be a main target to reduce CVD morbidity and mortality, notably in females. (J Am Coll Cardiol Basic Trans Science 2022;7:410???421 ) ?? 2022 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据